Presbyopia treatments | Patent Publication Number 20210008034

US 20210008034 A1
Patent NumberUS 11285134 B2
Application Number16791039
Filled DateFeb 14, 2020
Priority DateApr 24, 2018
Publication DateJan 14, 2021
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsAileen Morgan
Jihao Zhou
Mohammed Dibas
Haixia Liu
Michael R. Robinson
Anuradha Gore
Jaya Giyanani
Sungwook Lee
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.